SuperworthKymera Therapeutics shares outstanding KYMR
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 98.2M
- On a year earlier
- +22.0%
- more shares
Kymera Therapeutics had 98.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 22.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 89.9M | +12% |
| FY2024 | 80.1M | +37% |
| FY2023 | 58.5M | +1% |
| FY2022 | 57.9M | +13% |
| FY2021 | 51.4M | +15% |
| FY2020 | 44.6M | +2275% |
| FY2019 | 1.9M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 98.2M | +22% | |
| Q1 FY26 | 97.5M | +22% | |
| Q4 FY25 | 89.9M | +12% | |
| Q3 FY25 | 87.3M | +15% | |
| Q2 FY25 | 80.4M | +10% | |
| Q1 FY25 | 80.1M | +13% | |
| Q4 FY24 | 80.1M | +37% | |
| Q3 FY24 | 76.1M | +30% | |
| Q2 FY24 | 73.1M | +25% | |
| Q1 FY24 | 70.8M | +22% | |
| Q4 FY23 | 58.5M | +1% | |
| Q3 FY23 | 58.4M | +7% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Kymera Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.